Association of MMP-9 gene polymorphisms with Behçet's disease risk
- 1 March 2015
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 164 (1) , 18-24
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Matrix Metalloproteinase-9 -1562C/T Promoter Polymorphism Confers Risk for COPD: A Meta-AnalysisPLOS ONE, 2013
- TIRAP Ser180Leu polymorphism is associated with Behcet's diseaseRheumatology, 2011
- Interleukin‐4 Gene Polymorphisms Confer Behçet’s Disease in Turkish PopulationScandinavian Journal of Immunology, 2011
- The determination of matrix metalloproteinase 9 activity and gene expression levels in Behcet’s disease patients with aneurysmal complicationsClinical Rheumatology, 2010
- Matrix metalloproteinase-9gene polymorphisms in nasal polyposisBMC Medical Genetics, 2010
- Matrix metalloproteinases as modulators of inflammationSeminars in Cell & Developmental Biology, 2008
- Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanomaBMC Medical Genetics, 2007
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004
- Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascadeExperimental Cell Research, 2004
- Matrix Metalloproteinases as Novel Disease Markers in Takayasu ArteritisCirculation, 2003